Drug Profile
Research programme: therapeutic antibodies - ShangPharma
Alternative Names: H2L2 IgG; H2L2 IgG antibodies; Therapeutic antibodies - Harbour Antibodies/ShangPharmaLatest Information Update: 26 Dec 2016
Price :
$50
*
At a glance
- Originator ShangPharma
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified